Kyntra Bio, Inc. (KYNB) — Cash Flow Reinvestment Rate
Kyntra Bio, Inc. (KYNB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $13.00K (capex $13.00K ) from operating cash flow of $12.68 Million. Check earnings quality score of Kyntra Bio, Inc. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyntra Bio, Inc. Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Kyntra Bio, Inc. across 4 annual periods. Explore Kyntra Bio, Inc. (KYNB) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Kyntra Bio, Inc. (2013–2020)
Year-by-year capital reinvestment analysis for Kyntra Bio, Inc.. For live market cap and broader valuation context, see KYNB market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $3.99 Million | $81.60 Million | $3.99 Million | ▼ -72.2% |
| 2016 | 0.18x | $1.25 Million | $7.11 Million | $1.25 Million | ▼ -51.4% |
| 2014 | 0.36x | $8.12 Million | $22.41 Million | $8.12 Million | ▲ +37.9% |
| 2013 | 0.26x | $6.81 Million | $25.92 Million | $6.81 Million | — |